Fast Market Research

New Market Report Now Available: Jenrin Discovery, Inc. - Product Pipeline Review - 2013

New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research


Boston, MA -- (SBWIRE) -- 02/19/2014 -- Global Market Direct's pharmaceuticals report, "Jenrin Discovery, Inc. - Product Pipeline Review - 2013" provides data on the Jenrin Discovery, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Jenrin Discovery, Inc.'s corporate website, SEC filings, investor presentations and featured press releases, both from Jenrin Discovery, Inc. and industry-specific third party sources, put together by Global Markets Direct's team.


- Jenrin Discovery, Inc. - Brief Jenrin Discovery, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Jenrin Discovery, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Jenrin Discovery, Inc. with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Jenrin Discovery, Inc.'s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

View Full Report Details and Table of Contents

Reasons to Get This Report

- Evaluate Jenrin Discovery, Inc.'s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Jenrin Discovery, Inc. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Jenrin Discovery, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Jenrin Discovery, Inc..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Jenrin Discovery, Inc. and identify potential opportunities in those areas.

Companies Mentioned in this Report: Jenrin Discovery, Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Aurigene Discovery Technologies Limited - Product Pipeline Review - 2013
- Almac Discovery Ltd. - Product Pipeline Review - 2013
- Melior Discovery, Inc. - Product Pipeline Review - 2013
- Metabolic Syndrome - Pipeline Review, H2 2013
- Inflammatory Bowel Disease - Pipeline Review, H1 2013
- Pseudomonas Aeruginosa Infections - Pipeline Review, H1 2013
- AstraZeneca PLC - Product Pipeline Review - 2013
- Acute Lung Injury - Pipeline Review, H2 2013
- Ono Pharmaceutical Co., Ltd. - Product Pipeline Review - 2013
- Cancer Pain - Pipeline Review, H2 2013